CLINICO-ECONOMICAL IMPACT OF HTA IMPLEMENTATION ON CHEST PAIN DIAGNOSTIC MARKERS<br />Dott. FilippoBartoccioni<br />U.O. C...
WHY AN HTA ON CHEST PAIN DIAGNOSTIC MARKERS PRESCRIPTION? <br />TECHNOLOGY IMPROVEMENT          GUIDELINE MODIFICATION<br ...
METHODOLOGY OF TECHNOLOGY STUDY<br />Technologies<br />Yes,<br />Itshouldbeused<br />No Indication<br />X3= note<br />Clin...
INTERVENTION  OUTCOME  GRAPHICS<br />
CLINICAL  IMPACT  VERIFICATION  THROUGH STATISTICAL  ANALYSIS<br />CONFIDENCE INTERVAL CONTAINS<br />NUMBER ONE<br />NULL ...
ECONOMICAL ANALYSIS <br />
S. Camillo- Forlanini U.O. Formazione e Governo Clinico<br />APPROPRIATENESS AND ECONOMICAL IMPACT<br />We started from an...
Thank you <br />for your attention<br />Contacts:<br />nucleohta@gmail.com<br />NucleoHTA<br />
Upcoming SlideShare
Loading in …5
×

Presentazione markers cardiaci Uzbekistan

408
-1

Published on

Published in: Health & Medicine, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
408
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Presentazione markers cardiaci Uzbekistan

  1. 1. CLINICO-ECONOMICAL IMPACT OF HTA IMPLEMENTATION ON CHEST PAIN DIAGNOSTIC MARKERS<br />Dott. FilippoBartoccioni<br />U.O. Clinical Governance <br />S. Camillo – Forlanini Hospital<br />
  2. 2. WHY AN HTA ON CHEST PAIN DIAGNOSTIC MARKERS PRESCRIPTION? <br />TECHNOLOGY IMPROVEMENT GUIDELINE MODIFICATION<br />MAIN DIAGNOSTIC MARKERS OF CHEST PAIN: <br />TROPONIN I and T<br />CK-MB<br />MYOGLOBIN<br />
  3. 3. METHODOLOGY OF TECHNOLOGY STUDY<br />Technologies<br />Yes,<br />Itshouldbeused<br />No Indication<br />X3= note<br />Clinical presentations<br />
  4. 4. INTERVENTION OUTCOME GRAPHICS<br />
  5. 5. CLINICAL IMPACT VERIFICATION THROUGH STATISTICAL ANALYSIS<br />CONFIDENCE INTERVAL CONTAINS<br />NUMBER ONE<br />NULL HYPOTESIS IS CONFIRMED<br />THERE IS NOT ANY DIFFERENCE BETWEEN BEFORE AND AFTER THE INTERVENTION<br />
  6. 6. ECONOMICAL ANALYSIS <br />
  7. 7. S. Camillo- Forlanini U.O. Formazione e Governo Clinico<br />APPROPRIATENESS AND ECONOMICAL IMPACT<br />We started from an average of about 1100 myoglobin / month / PS’ s tests.The intervention led to a required’s reduction amounts to 96.78%.<br />
  8. 8. Thank you <br />for your attention<br />Contacts:<br />nucleohta@gmail.com<br />NucleoHTA<br />

×